MovDisordV3, PascalFrancis, Curation, bibRecord, 003690

Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease

Identifieur interne : 003690 ( PascalFrancis/Curation ); précédent : 003689; suivant : 003691

Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease

Auteurs : I. Soykan [États-Unis] ; I. Sarosiek [États-Unis] ; J. Shifflett [États-Unis] ; G. F. Wooten [États-Unis] ; R. W. Mccallum [États-Unis]

Source :

Movement disorders [ 0885-3185 ] ; 1997.

RBID : Pascal:98-0015577

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Dompéridone, Antiémétique, Evacuation gastrique, Estomac pathologie, Antagoniste, Traitement, Homme, Récepteur dopaminergique D2, Chimiothérapie, Voie orale.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Antagonist, Antiemetic, Chemotherapy, D2 Dopamine receptor, Domperidone, Gastric disease, Gastric emptying, Human, Oral administration, Parkinson disease, Treatment.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 12`
A06				`@2 6`
A08	`01`	`1`	`ENG`	`@1 Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease`
A11	`01`	`1`		`@1 SOYKAN (I.)`
A11	`02`	`1`		`@1 SAROSIEK (I.)`
A11	`03`	`1`		`@1 SHIFFLETT (J.)`
A11	`04`	`1`		`@1 WOOTEN (G. F.)`
A11	`05`	`1`		`@1 MCCALLUM (R. W.)`
A14	`01`			`@1 Department of Medicine, Health Science Center, University of Virginia @2 Charlottesville, Virginia @3 USA @Z 1 aut. @Z 3 aut. @Z 5 aut.`
A14	`02`			`@1 Kansas University Medical Center @2 Kansas City, Kansas @3 USA @Z 2 aut.`
A14	`03`			`@1 Department of Neurology, Health Sciences Center, University of Virginia @2 Charlottesville, Virginia @3 USA @Z 4 aut.`
A20				`@1 952-957`
A21				`@1 1997`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000069474290160`
A44				`@0 0000 @1 © 1997 INIST-CNRS. All rights reserved.`
A45				`@0 35 ref.`
A47	`01`	`1`		`@0 98-0015577`
A60				`@1 P`
A61				`@0 A`
A64		`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C02	`01`	`X`		`@0 002B02H`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Dompéridone @2 NK @2 FR @5 04`
C03	`02`	`X`	`ENG`	`@0 Domperidone @2 NK @2 FR @5 04`
C03	`02`	`X`	`SPA`	`@0 Domperidona @2 NK @2 FR @5 04`
C03	`03`	`X`	`FRE`	`@0 Antiémétique @5 05`
C03	`03`	`X`	`ENG`	`@0 Antiemetic @5 05`
C03	`03`	`X`	`SPA`	`@0 Antiemético @5 05`
C03	`04`	`X`	`FRE`	`@0 Evacuation gastrique @5 07`
C03	`04`	`X`	`ENG`	`@0 Gastric emptying @5 07`
C03	`04`	`X`	`SPA`	`@0 Vaciamiento gástrico @5 07`
C03	`05`	`X`	`FRE`	`@0 Estomac pathologie @5 10`
C03	`05`	`X`	`ENG`	`@0 Gastric disease @5 10`
C03	`05`	`X`	`SPA`	`@0 Estómago patología @5 10`
C03	`06`	`X`	`FRE`	`@0 Antagoniste @5 16`
C03	`06`	`X`	`ENG`	`@0 Antagonist @5 16`
C03	`06`	`X`	`SPA`	`@0 Antagonista @5 16`
C03	`07`	`X`	`FRE`	`@0 Traitement @5 17`
C03	`07`	`X`	`ENG`	`@0 Treatment @5 17`
C03	`07`	`X`	`GER`	`@0 Aufbereiten @5 17`
C03	`07`	`X`	`SPA`	`@0 Tratamiento @5 17`
C03	`08`	`X`	`FRE`	`@0 Homme @5 20`
C03	`08`	`X`	`ENG`	`@0 Human @5 20`
C03	`08`	`X`	`SPA`	`@0 Hombre @5 20`
C03	`09`	`X`	`FRE`	`@0 Récepteur dopaminergique D2 @5 23`
C03	`09`	`X`	`ENG`	`@0 D2 Dopamine receptor @5 23 @6 «D2» Dopamine receptor`
C03	`09`	`X`	`SPA`	`@0 Receptor dopaminérgico D2 @5 23`
C03	`10`	`X`	`FRE`	`@0 Chimiothérapie @5 24`
C03	`10`	`X`	`ENG`	`@0 Chemotherapy @5 24`
C03	`10`	`X`	`SPA`	`@0 Quimioterapia @5 24`
C03	`11`	`X`	`FRE`	`@0 Voie orale @5 35`
C03	`11`	`X`	`ENG`	`@0 Oral administration @5 35`
C03	`11`	`X`	`SPA`	`@0 Vía oral @5 35`
C07	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`03`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`03`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`05`	`X`	`FRE`	`@0 Maladie dégénérative @5 41`
C07	`05`	`X`	`ENG`	`@0 Degenerative disease @5 41`
C07	`05`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 41`
C07	`06`	`X`	`FRE`	`@0 Appareil digestif pathologie @5 61`
C07	`06`	`X`	`ENG`	`@0 Digestive diseases @5 61`
C07	`06`	`X`	`SPA`	`@0 Aparato digestivo patología @5 61`
N21				`@1 364`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003134

Links to Exploration step

Pascal:98-0015577

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease</title>
<author><name sortKey="Soykan, I" sort="Soykan, I" uniqKey="Soykan I" first="I." last="Soykan">I. Soykan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Medicine, Health Science Center, University of Virginia</s1>
<s2>Charlottesville, Virginia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Sarosiek, I" sort="Sarosiek, I" uniqKey="Sarosiek I" first="I." last="Sarosiek">I. Sarosiek</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Kansas University Medical Center</s1>
<s2>Kansas City, Kansas</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Shifflett, J" sort="Shifflett, J" uniqKey="Shifflett J" first="J." last="Shifflett">J. Shifflett</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Medicine, Health Science Center, University of Virginia</s1>
<s2>Charlottesville, Virginia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Wooten, G F" sort="Wooten, G F" uniqKey="Wooten G" first="G. F." last="Wooten">G. F. Wooten</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, Health Sciences Center, University of Virginia</s1>
<s2>Charlottesville, Virginia</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Mccallum, R W" sort="Mccallum, R W" uniqKey="Mccallum R" first="R. W." last="Mccallum">R. W. Mccallum</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Medicine, Health Science Center, University of Virginia</s1>
<s2>Charlottesville, Virginia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">98-0015577</idno>
<date when="1997">1997</date>
<idno type="stanalyst">PASCAL 98-0015577 INIST</idno>
<idno type="RBID">Pascal:98-0015577</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003134</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003690</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease</title>
<author><name sortKey="Soykan, I" sort="Soykan, I" uniqKey="Soykan I" first="I." last="Soykan">I. Soykan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Medicine, Health Science Center, University of Virginia</s1>
<s2>Charlottesville, Virginia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Sarosiek, I" sort="Sarosiek, I" uniqKey="Sarosiek I" first="I." last="Sarosiek">I. Sarosiek</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Kansas University Medical Center</s1>
<s2>Kansas City, Kansas</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Shifflett, J" sort="Shifflett, J" uniqKey="Shifflett J" first="J." last="Shifflett">J. Shifflett</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Medicine, Health Science Center, University of Virginia</s1>
<s2>Charlottesville, Virginia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Wooten, G F" sort="Wooten, G F" uniqKey="Wooten G" first="G. F." last="Wooten">G. F. Wooten</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, Health Sciences Center, University of Virginia</s1>
<s2>Charlottesville, Virginia</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Mccallum, R W" sort="Mccallum, R W" uniqKey="Mccallum R" first="R. W." last="Mccallum">R. W. Mccallum</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Medicine, Health Science Center, University of Virginia</s1>
<s2>Charlottesville, Virginia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1997">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antagonist</term>
<term>Antiemetic</term>
<term>Chemotherapy</term>
<term>D2 Dopamine receptor</term>
<term>Domperidone</term>
<term>Gastric disease</term>
<term>Gastric emptying</term>
<term>Human</term>
<term>Oral administration</term>
<term>Parkinson disease</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Dompéridone</term>
<term>Antiémétique</term>
<term>Evacuation gastrique</term>
<term>Estomac pathologie</term>
<term>Antagoniste</term>
<term>Traitement</term>
<term>Homme</term>
<term>Récepteur dopaminergique D2</term>
<term>Chimiothérapie</term>
<term>Voie orale</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>12</s2>
</fA05>
<fA06><s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>SOYKAN (I.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>SAROSIEK (I.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SHIFFLETT (J.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>WOOTEN (G. F.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>MCCALLUM (R. W.)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Medicine, Health Science Center, University of Virginia</s1>
<s2>Charlottesville, Virginia</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Kansas University Medical Center</s1>
<s2>Kansas City, Kansas</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurology, Health Sciences Center, University of Virginia</s1>
<s2>Charlottesville, Virginia</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>952-957</s1>
</fA20>
<fA21><s1>1997</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000069474290160</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1997 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>35 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>98-0015577</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02H</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Dompéridone</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Domperidone</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Domperidona</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Antiémétique</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Antiemetic</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Antiemético</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Evacuation gastrique</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Gastric emptying</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Vaciamiento gástrico</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Estomac pathologie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Gastric disease</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Estómago patología</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Antagoniste</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Antagonist</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Antagonista</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Traitement</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Treatment</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="GER"><s0>Aufbereiten</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Récepteur dopaminergique D2</s0>
<s5>23</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>D2 Dopamine receptor</s0>
<s5>23</s5>
<s6>«D2» Dopamine receptor</s6>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Receptor dopaminérgico D2</s0>
<s5>23</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>24</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>24</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>24</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Voie orale</s0>
<s5>35</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Oral administration</s0>
<s5>35</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Vía oral</s0>
<s5>35</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Appareil digestif pathologie</s0>
<s5>61</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Digestive diseases</s0>
<s5>61</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Aparato digestivo patología</s0>
<s5>61</s5>
</fC07>
<fN21><s1>364</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003690 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 003690 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:98-0015577
   |texte=   Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease

Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri